Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis
Ginecologia e ObstetríciaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
- Publicado em
- 19 dez 2024
- Citações
- 8
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis
Haiyue Wu, Lucia Li, Kun Fu, YuFei Shen, Yingnan Lu, Zexi Liao, Yingzhen Liu, Wenting Zha, Lisha Wu, Yu Zhang
Descritores MeSH
- Persistent Infection
- Uterine Cervical Neoplasms
- Papillomavirus Infections
- Human papillomavirus 18
- Human papillomavirus 16
- Papillomavirus Vaccines
- Uterine Cervical Dysplasia
- Human Papillomavirus Viruses
- Vaccination
- Randomized Controlled Trials as Topic
Veja também
Estudos relacionados
- Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions
- Maximizing impact: the power of early HPV vaccination for long-term protection-lessons from a systematic review and meta-regression analysis
- Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase III, double-blind, randomized, controlled trial
- Controlled trial of cervical cancer screening frequency among human-papillomavirus-vaccinated women